By proceeding, you agree to our Terms of Use and Privacy Policy.
For decades, RAS has existed as an elusive therapeutic target, and drugging this high-value oncogene was deemed impossible. Despite this, the first-ever FDA-approved KRAS G12C inhibitor has demonstrated that RAS is in fact druggable and that drugging this protein unlocks a world of successful therapeutic interventions.
Bigger and better than ever before, the event will bring together 300+ experts to showcase 3-days of exclusive, never shared before data.
As the industry delves into accelerating discovery and emerging strategies, optimizing translation and pre-clinical development etc.
The event will be uniting all experts from across the globe to spend 3 days in Boston, learning, discussing, and progressing anti-RAS therapies to the patient.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Reaction Biology provides pre-clinical drug discovery solutions as your trusted partner.
Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data.
Founded in 2013, Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development.
BPS manufactures one of the largest selections of recombinant enzymes, neutralizing antibodies, inhibitor assay kits, lentiviruses and cell lines for drug discovery and continues to expand its drug discovery products.
Helping patients fight treatment resistant cancer. Resistance Bio can discover and overcome clinical treatment resistance pre-clinically.
Nanome is a software company that is changing the way humanity understands and interacts with science. Using Virtual Reality our technology accelerates innovation and understanding in an intuitive manner.
A leading data-driven diagnostic solutions company helping answer critical clinical questions faced by physicians, researchers, and biopharmaceutical companies, with a primary focus in lung disease.
At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems.
RockStep is digitally transforming in vivo research with Climb, our collaboration suite for managing in vivo operations and data.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.